Cody Baxter, PA-C

11/21/2025

I spent 42 minutes on the phone for one medication review. I was transferred around, told different numbers, put on hold and the supervisor never called me back.

I am not sharing this for sympathy. This is simply the reality of getting patients the care they need. At a small independent clinic, there is no separate department that handles this.

It is slow and it is frustrating, but the person on the other side of that approval deserves someone who will stay with it.

Insurance companies make this process harder than it needs to be, and the providers and patients pay the price for it.

05/23/2025

Quick summary: GLP-1 medications improve mental health with very few exceptions.

This review covered 80 different research studies involving 107,000 patients. GLP-1 use was associated with improved quality of life and mental well-being. This aligns with what I've seen for years on the clinical side with my patients.

It is still important to monitor each patient's mental health because there are some rare occasions when patients have felt their mood worsen. Luckily, the mood changes were relatively minor and always improved after adjusting the dose or stopping medication.

https://www.medscape.com/viewarticle/new-data-glp-1-ras-and-psychiatric-side-effects-2025a1000cu8?fbclid=IwY2xjawKdqIBleHRuA2FlbQIxMABicmlkETEySzNweWNRbkpoZ0Q0Tmx6AR7cQd2BfHf3WBBqWFC75u7DcCW6oZKZJxEtlZlzPoGjg1PjvXT_hROOJtIz3g_aem_z0QaC3Bq3VZSJaZ5mLPhmQ

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without preexisting mental illness.

05/17/2025

05/16/2025

Holy smokes! We are incredibly grateful to have been chosen as a finalist for Emerging Business of the Year at ’s Chamber Choice Awards yesterday.

I have deep gratitude for everyone who has helped make this dream a reality over the past 2 years, starting with these two women. My wife and marketing maven, , and business partner and tireless entrepreneur, .severson, represented well!

This is a team effort, including past and present staff, who have shown up day after day with the goal of helping patients become the happiest, healthiest version of themselves. We are so much more than a weight management clinic (even though we’re pretty good at that, too!) and we are excited to continue building on this success and changing the future of obesity and cardiometabolic medicine!

04/23/2025

She’s the marketing director, of course she has creative ideas!

04/11/2025

04/10/2025

Senator Fetterman shared his story of having a stroke and subsequently incorporating tirzepatide as part of his plan to regain his health. His story reflects what we see in our practice on a regular basis, and I thank him for his advocacy.

Unfortunately, the current administration has reversed the Biden administration’s proposal to add Medicare forr GLP1 drugs for treatment of obesity.

I remain optimistic the long-term arc bends toward better coverage, but we need to continue pushing our legislators to expand coverage and regulate profit-driven insurance companies and pharmacy benefits managers to make these medicines more affordable.

https://www.nytimes.com/2025/04/08/opinion/glp1-ozempic-mounjaro-trump.html?smid=nytcore-ios-share&referringSource=articleSharee

The government should make it easier to get access to GLP-1s.

04/03/2025

Join our team and show us if you can shimmy better than Stephanie Severson and me!

03/28/2025

Guilty as charged!